Literature DB >> 6200616

Glycosaminoglycans of human prostatic cancer.

D P De Klerk, D V Lee, H J Human.   

Abstract

The glycosaminoglycans of normal, benign hyperplastic and cancerous prostate were studied. In both prostatic hyperplasia and cancer the chondroitin sulfate:dermatan sulfate ratio was increased. In prostatic cancer this increase correlated with both the differentiation and extent of cancer in the prostate. The percentages heparan sulfate and heparan sulfate sulfation were decreased in prostatic cancer. Hyaluronic acid increased with dedifferentiation of the cancer. Histochemically, sulfated glycosaminoglycans were concentrated in the prostatic stroma at the stromal-epithelial interface. The increased chondroitin sulfate:dermatan sulfate ratio may be a nonspecific response or requirement for epithelial growth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200616     DOI: 10.1016/s0022-5347(17)50750-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.

Authors:  Melanie A Simpson
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  The accumulation of versican in the nodules of benign prostatic hyperplasia.

Authors:  Lawrence D True; Sarah Hawley; Thomas H Norwood; Kathleen R Braun; Stephen P Evanko; Christina K Chan; Richard C LeBaron; Thomas N Wight
Journal:  Prostate       Date:  2009-02-01       Impact factor: 4.104

3.  Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.

Authors:  Thomas Mandel Clausen; Marina Ayres Pereira; Nader Al Nakouzi; Htoo Zarni Oo; Mette Ø Agerbæk; Sherry Lee; Maj Sofie Ørum-Madsen; Anders Riis Kristensen; Amal El-Naggar; Paul M Grandgenett; Jean L Grem; Michael A Hollingsworth; Peter J Holst; Thor Theander; Poul H Sorensen; Mads Daugaard; Ali Salanti
Journal:  Mol Cancer Res       Date:  2016-09-21       Impact factor: 5.852

4.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

Review 5.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

Review 6.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

7.  Cytochemical localisation and characterisation of proteoglycans (glycosaminoglycans) in the epithelial-stromal interface of the seminal vesicle of the guinea pig.

Authors:  L Chan; Y C Wong
Journal:  J Anat       Date:  1992-02       Impact factor: 2.610

8.  Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice.

Authors:  Melanie A Simpson; Christopher M Wilson; James B McCarthy
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Localization and quantity of hyaluronan in urogenital organs of male and female rats.

Authors:  C Laurent; S Hellström; A Engström-Laurent; A F Wells; A Bergh
Journal:  Cell Tissue Res       Date:  1995-02       Impact factor: 5.249

Review 10.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.